Sturge-Weber syndrome (SWS) is a rare, congenital (present at birth), noninherited disorder characterized by the vascular malformation (birthmark) called a port wine stain, usually seen on an infant's face. Sturge-Weber also is characterized by neurological abnormalities including seizures, weakness on one side of the body, developmental delay, and glaucoma (increased pressure within the eye). Other terms for SWS are: encephalotrigeminal angiomatosis, encephalofacial angiomatosis, or Sturge-Weber-Dimitri syndrome.
Sturge-Weber syndrome is named for the British physicians William A. Sturge (1850–1919), who first described the condition, and Frederick Parkes Weber (1863–1962) who demonstrated its intracranial calcifications.
SWS is a rare congenital disorder whose most apparent indication is a port wine stain on the face that is associated with neurological abnormalities. The port wine stain is a benign tumor just under the surface of the skin, made up of overabundant blood vessels (angiomas). Port wine stain may affect either or both sides of the face and can vary in size. Other neurological abnormalities may be present, including angioma on the brain's surface.
The incidence of SWS is estimated at one per 50,000 live births in the United States. No regional or gender differences have been noted. An estimated 13 percent of individuals with SWS will not have the port wine stain. In addition, some children with port wine stain may not have Sturge-Weber syndrome.
The exact cause and incidence of Sturge-Weber syndrome was as of 2004 not understood. It is not thought to be genetic.
A child born with SWS has a higher likelihood of the following clinical signs of the disorder:
The following manifestations of SWS may be present:
An infant born with a port wine stain will be immediately evaluated by healthcare staff. In some cases, infants with SWS will not have a port wine stain present at birth. In these cases, suspicion of SWS may not arise until a child has a seizure or other neurological problem.
Clinical diagnosis of SWS begins with the observation of port wine stain in an infant. The port wine stain may not be obvious in children of color. Not all children with port wine stain will have SWS, however; and some children with SWS will not have port wine stain. In the absence of port wine stain, other neurological abnormalities will help determine the diagnosis. Seizures may be the first symptoms of SWS in a child, usually by the first year. The seizures are usually frequent and may be prolonged. If glaucoma is involved, there may be no symptoms in older children. Infants may avoid bright light as a result of enlarged corneas.
If neurological involvement is suspected, the following tests may be used to help make a diagnosis:
Treatment for SWS depends on the disorder involved.
SWS is not a fatal disease. The prognosis for SWS depends on the specific neurological abnormalities present. Some abnormalities associated with SWS may worsen with age. Successful treatment of seizures improves the outlook for children with SWS.
There was as of 2004 no known way to prevent SWS. Nothing a parent has done or did not do causes the disorder.
The seizures that are often present with SWS can place children in potentially dangerous situations.
Angioma—A tumor (such as a hemangioma or lymphangioma) that mainly consists of blood vessels or lymphatic vessels.
Anomaly—Something that is different from what is normal or expected. Also an unusual or irregular structure.
Capillaries—The tiniest blood vessels with the smallest diameter. These vessels receive blood from the arterioles and deliver blood to the venules. In the lungs, capillaries are located next to the alveoli so that they can pick up oxygen from inhaled air.
Choroidal hemangioma—A nonmalignant blood vessel tumor in the eye.
Hemianopsia—Loss of half of the field of vision.
Hemiparesis—Weakness on one side of the body.
See also Seizure disorder.
Baselga, E. "Sturge-Weber syndrome." Seminars in Cutaneous Medicine and Surgery 23, no. 2 (June 2004): 87–98.
Lam, Samuel, et al. "Practical Considerations in the Treatment of Capillary Vascular Malformations, or Port Wine Stains." Facial Plastic Surgery (2004): 71–6.
Thomas-Sohl, K. A., et al. "Sturge-Weber syndrome: a review." Pediatric Neurology 30 (May 2004): 303–10.
American Academy of Dermatology. 930 E. Woodfield Rd., Schaumburg, IL 60168. Web site: <www.aad.org/>
Children's Hemiplegia and Stroke Association. Suite 305, PMB 149 4101 W. Green Oaks. Arlington, TX 76016. Web site: <www.hemikids.org/hemiplegia.htm>.
FACES: The National Craniofacial Association. PO Box 11082, Chattanooga, TN 37401. Web site: <www.facescranio.org/>.
National Association for Rare Disorders. 55 Kenosia Avenue, PO Box 1968, Danbury, CT 06813–1968. Web site: <www.rarediseases.org/info/contact.html>.
Sturge-Weber Foundation. PO Box 418, Mount Freedom, NJ 07970. Web site: <www.sturge-weber.com/>.
"NINDS Sturge-Weber Syndrome Information Page." National Institute of Neurological Disorders and Stroke, 2001. Available online at <www.ninds.nih.gov/health_and_medical/disorders/sturge_doc.htm> (accessed November 30, 2004).
Sturge-Weber Foundation. Available online at <www.sturgeweber.com> (accessed November 30, 2004).
"Sturge-Weber Syndrome." eMedicine, 2001. Available online at <www.emedicine.com/neuro/topic356.htm#section~workup> (accessed November 30, 2004).
"Sturge-Weber Syndrome." Epilepsy Action. Available online at <www.epilepsy.org.uk/info/sturge.html> (accessed November 30, 2004).
Christine Kuehn Kelly